Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03128658 · ClinicalTrials.gov registry record
Trauma Induced Coagulopathy and Inflammation
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 300
- Enrollment target
NCT03128658: Completed study, sponsored by University of Pennsylvania.
NCT03128658 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03128658 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
While a number of factors are known to be associated with the development of trauma induced coagulopathy (TIC), inflammation, and multi-organ failure, we currently cannot predict which patients are at risk for developing these life threatening conditions with any certainty. In this prospective observational study, we will investigate the many factors that contribute to the development of trauma induced coagulopathy, post injury inflammation and the development of organ dysfunction in order to develop a multi scale computational algorithm of clinical prediction. Using a convenience sample technique, demographic data, physiologic data, blood samples and clinical variables will be collected over 5 days following traumatic injury. A computational model will be used to predict the development of TIC and multi-organ failure.
Interventions
- DIAGNOSTIC_TEST Thromboelastography
- DIAGNOSTIC_TEST Computational model
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2017-02-27 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03128658
The ClinicalTrials.gov registry entry for NCT03128658 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Thromboelastography is the first listed.
NCT03128658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03128658 about?
NCT03128658 is a clinical study titled "Trauma Induced Coagulopathy and Inflammation". While a number of factors are known to be associated with the development of trauma induced coagulopathy (TIC), inflammation, and multi-organ failure, we currently cannot predict which patients are at risk for developing these life threatening conditions with any certainty. In this prospective obser...
What is the current status of trial NCT03128658?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2017-02-27. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03128658?
The interventions under investigation include: Thromboelastography (DIAGNOSTIC_TEST), Computational model (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03128658?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.